CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autore principale: | Ullah, Mohammad |
---|---|
Altri autori: | Islam, Farzana |
Natura: | Tesi |
Lingua: | English |
Pubblicazione: |
Brac University
2023
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/19355 |
Documenti analoghi
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
di: Maria, Amatul
Pubblicazione: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
di: Shaikat, Mahdi Mubin
Pubblicazione: (2023) -
A review on CRISPR-Cas system based applications in Oncology
di: Sadia, Mir
Pubblicazione: (2022) -
A review on CRISPR Technology as an Antiviral Tool
di: Srishti, Sanjida Ahmed
Pubblicazione: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
di: Eva, Israt Ara Jannat
Pubblicazione: (2023)